Effect of celecoxib on hepatic and renal functions in rats with mammary carcinoma

Yushi YAO,Yueqing QIAN,Zhonghe YU

DOI: https://doi.org/10.3969/j.issn.1004-3594.2011.11.018

2011-01-01

Abstract:Objective To evaluate the effect of celecoxib,a selective cyclooxygenase-2 inhibitor,on the hepatic and renal functions of rats with chemically induced mammary carcinoma.Methods A single dose of 7,12 dimethgylbenz anthracene was administered i.g.into female SD rats to induce mammary carcinoma,during which celecoxib was given at various doses.Hepatic and renal functions were determined and statistically analyzed in rats receiving various doses of celecoxib.Results Four weeks into the experiment, hepatic and renal functions in none of the groups were significantly different.The same was true of hepatic functions on week 17, when serum creatinine levels in 100 mg/kg and 150 mg/kg celecoxib groups were significantly different,compared with those in model control group(P<0.01).However,the serum creatinine level in 50 mg/kg celecoxib group was not significantly different from that in model control group(P>0.05).Conclusions Prophylactic administration of celecoxib in rats with DMBA-induced breast tumors is safe,though prolonged administration of celecoxib at high doses results in impaired renal function.Further studies are required to validate its safety profiles in clinical application.